<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immunology Product Guide &#187; allergic rhinitis</title>
	<atom:link href="http://www.immunologyproductguide.com/blog/tag/allergic-rhinitis/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.immunologyproductguide.com/blog</link>
	<description>A comprehensive guide to immunology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 10:09:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Allergy Vaccinations Reduce Children&#8217;s Health Care Costs By One-Third</title>
		<link>http://www.immunologyproductguide.com/blog/2010/01/13/allergy-vaccinations-reduce-childrens-health-care-costs-by-one-third/</link>
		<comments>http://www.immunologyproductguide.com/blog/2010/01/13/allergy-vaccinations-reduce-childrens-health-care-costs-by-one-third/#comments</comments>
		<pubDate>Wed, 13 Jan 2010 08:38:48 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Allergies]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[allergy immunotherapy]]></category>
		<category><![CDATA[American College of Allergy]]></category>
		<category><![CDATA[Annals of Allergy Asthma & Immunology]]></category>
		<category><![CDATA[Asthma and Immunology (ACAAI)]]></category>

		<guid isPermaLink="false">http://www.immunologyproductguide.com/blog/?p=218</guid>
		<description><![CDATA[Allergy immunotherapy, generally referred to as allergy vaccinations or shots, reduce total health care costs in children with allergic rhinitis by one-third, and prescription costs by 16 percent, according to a study published this month in Annals of Allergy, Asthma &#38; Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI). [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.immunologyproductguide.com/blog/wp-content/uploads/2010/01/Annals-of-Allergy-Asthma-Immunology.png"><img class="alignleft size-full wp-image-220" style="margin: 5px" src="http://www.immunologyproductguide.com/blog/wp-content/uploads/2010/01/Annals-of-Allergy-Asthma-Immunology.png" border="0" alt="Annals of Allergy, Asthma &amp; Immunology," width="200" height="75" /></a>Allergy immunotherapy, generally referred to as allergy vaccinations or shots, reduce total health care costs in children with allergic rhinitis by one-third, and prescription costs by 16 percent, according to a study published this month in Annals of Allergy, Asthma &amp; Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI). Allergic rhinitis is the third most common chronic disease in children, affecting up to 40 percent of the population.</p>
<p>For the full article, <a href="http://www.medicalnewstoday.com/articles/175610.php" target="_blank">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.immunologyproductguide.com/blog/2010/01/13/allergy-vaccinations-reduce-childrens-health-care-costs-by-one-third/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA nod to Cypress&#8217; Cetirizine HCl Oral Solution</title>
		<link>http://www.immunologyproductguide.com/blog/2008/11/06/fda-nod-to-cypress-cetirizine-hcl-oral-solution/</link>
		<comments>http://www.immunologyproductguide.com/blog/2008/11/06/fda-nod-to-cypress-cetirizine-hcl-oral-solution/#comments</comments>
		<pubDate>Thu, 06 Nov 2008 10:35:27 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Allergies]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[allergy]]></category>
		<category><![CDATA[Cetirizine HCl Oral Solution]]></category>
		<category><![CDATA[Cypress Pharmaceutical]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[generic]]></category>

		<guid isPermaLink="false">http://www.immunologyproductguide.com/blog/2008/11/06/fda-nod-to-cypress-cetirizine-hcl-oral-solution/</guid>
		<description><![CDATA[The U.S. Food and Drug Administration has granted approval to Cypress Pharmaceutical, Inc.’s abbreviated new drug application for the prescription and over-the-counter versions of Cetirizine Hydrochloride Oral Solution, 1 mg/1 mL. This product is an AA-rated generic equivalent to the Zyrtec® Oral Solution developed by McNeil Consumer Healthcare. While Cetirizine HCl Oral Solution’s over-the-counter version [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.immunologyproductguide.com/blog/wp-content/uploads/2008/11/cypress.png" align="left" height="60" hspace="5" vspace="5" width="200" />The U.S. Food and Drug Administration has granted approval to <a href="http://www.cypressrx.com">Cypress Pharmaceutical, Inc.</a>’s abbreviated new drug application for the prescription and over-the-counter versions of Cetirizine Hydrochloride Oral Solution, 1 mg/1 mL. This product is an AA-rated generic equivalent to the Zyrtec® Oral Solution developed by McNeil Consumer Healthcare. While Cetirizine HCl Oral Solution’s over-the-counter version is an antihistamine that relieve from indoor and outdoor allergies such as sneezing, runny nose, watery eyes and itchy throat; the prescription version treats symptoms of allergic rhinitis in children who are 6 to 23 months of age and relieve children up to 5 years of age from chronic urticaria (hives).</p>
]]></content:encoded>
			<wfw:commentRss>http://www.immunologyproductguide.com/blog/2008/11/06/fda-nod-to-cypress-cetirizine-hcl-oral-solution/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study finds preventative effect of SLIT</title>
		<link>http://www.immunologyproductguide.com/blog/2008/09/30/study-finds-preventative-effect-of-slit/</link>
		<comments>http://www.immunologyproductguide.com/blog/2008/09/30/study-finds-preventative-effect-of-slit/#comments</comments>
		<pubDate>Tue, 30 Sep 2008 07:41:33 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Allergies]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[Macchi Hospital]]></category>
		<category><![CDATA[SLIT]]></category>

		<guid isPermaLink="false">http://www.immunologyproductguide.com/blog/2008/09/30/study-finds-preventative-effect-of-slit/</guid>
		<description><![CDATA[Researchers at Macchi Hospital in Varese, Italy have proposed that sublingual immunotherapy (SLIT) can prove beneficial in preventing mild persistent asthma and new skin sensitizations in children suffering from allergic rhinitis. The doctors also report that the therapy has the potential to reduce bronchial hyperactivity. Based on the 3-year long study, SLIT was found to [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.immunologyproductguide.com/blog/wp-content/uploads/2008/09/univ-insurbia.png" align="left" height="206" hspace="5" vspace="5" width="200" />Researchers at Macchi Hospital in Varese, Italy have proposed that sublingual immunotherapy (SLIT) can prove beneficial in preventing mild persistent asthma and new skin sensitizations in children suffering from allergic rhinitis. The doctors also report that the therapy has the potential to reduce bronchial hyperactivity. Based on the 3-year long study, SLIT was found to be safe for children, when used in the recommended doses.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.immunologyproductguide.com/blog/2008/09/30/study-finds-preventative-effect-of-slit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
